NDC 51672-4045-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4045
- Requested NDC
- 51672-4045-01
- Package NDCs from labels
- 51672-4045-1, 51672-4045-3, 51672-4045-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4045-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4045-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4045 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4045-1 | EA - Each | 51672-4045 | 65069710-3c5b-4339-ba87-09ceb26cf720 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | eac57b4c-e79b-8d35-e053-2a95a90a9d25 | 2026-06-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Enalapril Maleate Oral Solution | ENALAPRIL MALEATE ORAL SOLUTION | Ascend Laboratories, LLC | 964d561a-2e04-4ad9-9762-932419ee19ae | 2026-06-19 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | d8516f38-6f92-32d1-e053-2995a90a96bf | 2026-06-19 | Warnings, Adverse reactions | 8MDF5V39QO |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Bicarbonate | SODIUM BICARBONATE, INJECTION | Civica, Inc. | 3737e5e5-2296-4a3d-b8f1-dfea1eff1927 | 2026-06-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | 8MDF5V39QO |
| Calamine, Pramoxind HCl | CALAMINE, PRAMOXIND HCL | H E B | 4a7a0b09-d9bc-e752-e063-6394a90a9f2c | 2026-06-15 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine, Zinc Oxide | CALAMINE, ZINC OXIDE | H E B | 4a79259e-64ac-d187-e063-6294a90a78db | 2026-06-15 | Warnings, Adverse reactions | 1K09F3G675 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Leading Pharma, LLC | 8c868894-667e-4a51-906a-838d63e420ba | 2026-06-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 54113d1f-e8e7-6b4c-e063-6394a90a0edf | 2026-06-12 | Warnings | 059QF0KO0R |
| Sodium Bicarbonate | SODIUM BICARBONATE | Cardinal Health 107, LLC | 60c2a176-8854-4479-b853-d07fe9a1830c | 2026-06-12 | Warnings | 8MDF5V39QO |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | BM Private Limited | 53fa21d9-1f80-2e69-e063-6394a90ab9f3 | 2026-06-11 | Warnings | 059QF0KO0R |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC. | 5401e4ff-aa7a-3e97-e063-6294a90a24f0 | 2026-06-11 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | 2f05947f-a489-4298-a871-90db75b2a6c5 | 2026-06-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | cdf59426-2a2f-4a60-943a-e6cef3eb31e1 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| XIMONTH Fungi Free Bee Venom Nail Soothing Serum | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 53bab969-8407-6334-e063-6294a90aa5d1 | 2026-06-08 | Warnings | 059QF0KO0R |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5eabb13d-f6fd-4091-9909-c4f0c5922289 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | NCS HealthCare of KY, LLC dba Vangard Labs | fde4ea0c-152b-4b79-a6d8-2b0dbd9107aa | 2026-06-04 | Warnings | 8MDF5V39QO |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | 099496f1-4e2d-8d21-e063-6294a90af695 | 2026-06-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 43425ec7-a2c0-41d8-b759-b7b5918949ce | 2026-06-01 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.